Back to search
Intraductal Carcinoma and Lobular Carcinoma in Situ
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Intraductal Carcinoma and Lobular Carcinoma in Situ trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Intraductal Carcinoma and Lobular Carcinoma in Situ trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
To evaluate whether the combination of clinicopathological factors and the use of the Oncotype DX DCIS score can avoid radiation in women with low risk DCIS who…
This phase II trial evaluates response-guided low-dose tamoxifen for reducing breast density in women who are at higher than average risk for breast cancer. Inc…
This study evaluates the association of dietary inflammatory potential with breast cancer risk. Information collected in this study may help doctors to identify…
This trial will investigate a novel 3-fraction radiation regimen for participants undergoing breast-conserving therapy (BCT) for early breast cancer that will:…
This prospective, multicenter cohort study investigates the differences in the reliability of rapid pathology compared to postoperative pathology when utilizing…
The standard surgical approach for all patients undergoing mastectomy for the treatment of non-invasive, ductal carcinoma in situ (DCIS) is to perform axillary…
The purpose of this study is to determine if wide excision (surgical removal) alone is adequate treatment for small, grade 1 or 2 ductal carcinoma in situ (DCIS…
This randomized phase III clinical trial studies how well tamoxifen citrate, anastrozole, letrozole, or exemestane with or without chemotherapy work in treating…